STOCK TITAN

Ionis to present at upcoming investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Ionis Pharmaceuticals, Inc. (IONS) will participate in several investor conferences in 2024, including the Needham Virtual Healthcare Conference, RBC Capital Markets Global Healthcare Conference, BofA Securities Health Care Conference, and Goldman Sachs Global Healthcare Conference. The presentations can be accessed via webcast on the Ionis website, with replays available within 48 hours.
Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024
  • 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024
  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024
  • 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302102970.html

SOURCE Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals will participate in the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024.

The live webcast of Ionis Pharmaceuticals' presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events.

Replays of Ionis Pharmaceuticals' presentations will be available on the Ionis website within 48 hours and will be archived for a time.
Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Stock Data

6.12B
144.53M
0.86%
100.99%
6.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CARLSBAD

About IONS

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.